Fertility Biomarkers
Open Access
Misoprostol (Cytotec) for Prevention of Ovarian Hyperstimulation Syndrome. A Preliminary Investigation.
Mar 2019 DOI 10.14302/issn.2576-2818.jfb-19-2637
Leonardo FormigliCorresponding author
This preliminary study explores misoprostol as a preventive strategy for ovarian hyperstimulation syndrome. It outlines rationale, dosing considerations, and early safety signals, and calls for controlled trials to establish efficacy and risk–benefit.